Your browser doesn't support javascript.
loading
Emicizumab prophylaxis: Prospective longitudinal real-world follow-up and monitoring.
Barg, Assaf A; Budnik, Ivan; Avishai, Einat; Brutman-Barazani, Tami; Bashari, Dalia; Misgav, Mudi; Lubetsky, Aaron; Kuperman, Amir A; Livnat, Tami; Kenet, Gili.
Afiliação
  • Barg AA; Sheba Medical Center, National Hemophilia Center, Tel Hashomer, Israel.
  • Budnik I; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Avishai E; Department of Pathophysiology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Brutman-Barazani T; Sheba Medical Center, National Hemophilia Center, Tel Hashomer, Israel.
  • Bashari D; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Misgav M; Sheba Medical Center, National Hemophilia Center, Tel Hashomer, Israel.
  • Lubetsky A; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Kuperman AA; Sheba Medical Center, National Hemophilia Center, Tel Hashomer, Israel.
  • Livnat T; Sheba Medical Center, National Hemophilia Center, Tel Hashomer, Israel.
  • Kenet G; Sheba Medical Center, National Hemophilia Center, Tel Hashomer, Israel.
Haemophilia ; 27(3): 383-391, 2021 May.
Article em En | MEDLINE | ID: mdl-33892524

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Hemofilia A Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Haemophilia Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Hemofilia A Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Haemophilia Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel